Revvity Unveils Revolutionary Discovery Platforms at SLAS2026

Revvity has unveiled new high-impact discovery platforms, including the Opera Phenix OptIQ high-content screening system, EnVision Nexus One multimode plate reader, and AssayMate workstation, at SLAS2026. These platforms aim to accelerate high-throughput drug discovery workflows and integrate automation, trusted assay technologies, and AI-driven imaging to help customers achieve faster results while maintaining data quality.